Trials / Not Yet Recruiting
Not Yet RecruitingNCT07192263
Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This Phase 3 study is designed to evaluate the efficacy and safety of IN-B00009 injection in adults with obesity or overweight without diabetes mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IN-B00009 | Test drug |
| DRUG | Placebo | Placebo drug |
Timeline
- Start date
- 2025-09-22
- Primary completion
- 2026-12-31
- Completion
- 2027-09-30
- First posted
- 2025-09-25
- Last updated
- 2025-09-25
Source: ClinicalTrials.gov record NCT07192263. Inclusion in this directory is not an endorsement.